| Patents for A61K 35 - Medicinal preparations containing material or reaction products thereof with undetermined constitution (125,838) |
|---|
| 09/02/2004 | US20040170613 Compositions and methods for liver growth and liver protection |
| 09/02/2004 | US20040170612 Injectable polysaccharide-cell compositions |
| 09/02/2004 | US20040170611 culturing an autologous or allogenic dermal papilla cell in the presence of a Wnt polypeptide or a fragment or analog thereof, and grafting the cultured cell onto the skin |
| 09/02/2004 | US20040170610 Compositions comprising bone marrow cells together with demineralized and/or mineralized bone matrix and uses thereof in the induction of bone and cartilage formation |
| 09/02/2004 | US20040170607 Reducing viability of tumor cells by administering a virus; differential sensitivity using interferons |
| 09/02/2004 | DE10306331A1 Preparation of biocomplex-reaction pattern in vertebrate cells components, useful for diagnosis, treatment and prevention of e.g. viral infections, includes purification with specific antibodies |
| 09/02/2004 | DE10253129A1 Wound healing or skin-care agent for treating skin defects or burns contains sea buckthorn oil, St. John's wort oil, propolis and 'Mumie' |
| 09/02/2004 | DE10026789B4 Knorpelersatz und Verfahren zu dessen Herstellung Cartilage replacement and process for its preparation |
| 09/02/2004 | CA2514485A1 Compositions comprising fetal hemoglobin and bacterial endotoxin and optionally additional fetal liver components |
| 09/01/2004 | EP1452594A1 Inducer for differentiation of embryo stem cells into ectodermal cells, method of obtaining the same and use thereof |
| 09/01/2004 | EP1452587A1 Stem cells originating in salivary duet epithelial cells and use thereof |
| 09/01/2004 | EP1452586A1 METHOD OF INDUCING DIFFERENTIATION OF MESODERMAL STEM CELLS, ES CELLS OR IMMORTALIZED CELLS INTO NERVOUS SYSTEM CELLS |
| 09/01/2004 | EP1452181A1 Regulation of immune responses by manipulation of intermediary metabolite levels |
| 09/01/2004 | EP1451333A2 Ul16 binding protein 4 |
| 09/01/2004 | EP1451323A2 Pharmaceutical compositions of marine sponge microciona prolifera |
| 09/01/2004 | EP1451303A1 Detection of haematopoietic stem cells and progeny and uses thereof |
| 09/01/2004 | EP1451302A1 In vitro reconstituted sheets of human corneal epithelium and method of producing the same |
| 09/01/2004 | EP1451300A2 Methods and compositions for the use of stromal cells to support embryonic and adult stem cells |
| 09/01/2004 | EP1451298A2 Cell and tissue growth using substances that reversibly bind oxygen |
| 09/01/2004 | EP1451294A2 Nutrient medium for maintaining neural cells in injured nervous system |
| 09/01/2004 | EP1451222A2 Novel proteins with il-6 inhibiting activity |
| 09/01/2004 | EP1451151A1 Hydroperylene derivatives |
| 09/01/2004 | EP1450892A2 Manual processing systems and methods for providing blood components conditioned for pathogen inactivation |
| 09/01/2004 | EP1450872A1 Composition and method for treatment of wounds |
| 09/01/2004 | EP1450862A1 Replication competent dual-ad vectors for vaccine and immunotherapy applications |
| 09/01/2004 | EP1450854A2 Vaccine |
| 09/01/2004 | EP1450832A2 Lactic acid bacteria and their use for treating and preventing cancer |
| 09/01/2004 | EP1450831A2 Methods of treatment in situ in the lungs of mammals |
| 09/01/2004 | EP1450830A2 Minor histocompatibility antigen ha-1: target antigen for immunotherapy of tumors |
| 09/01/2004 | EP1450828A2 In situ immunization |
| 09/01/2004 | EP1450827A1 Two-constituent compositions for the in situ production of cell transplants that comprise fibroblasts and keratinocytes |
| 09/01/2004 | EP1450626A1 A novel non-antibiotic strategy against ogip infections based on an activated cereal product or ferric quinate |
| 09/01/2004 | EP1450610A2 Probiotic compositions |
| 09/01/2004 | EP1450604A2 Method for extending the useful shelf-life of refrigerated red blood cells by nutrient supplementation |
| 09/01/2004 | EP1121064B1 Method and device for preparing a dental implant by immersion in a mesenchymal cell culture |
| 09/01/2004 | EP1089745B1 Oregano for the treatment of internal parasites and protozoa |
| 09/01/2004 | EP1014787B1 Adjuvant for transcutaneous immunization |
| 09/01/2004 | EP0975764B1 A gene delivery vehicle expressing the apoptosis-inducing proteins vp2 and/or apoptin |
| 09/01/2004 | EP0831862B1 Method of manufacturing a composition comprising modified animal lung surfactant |
| 09/01/2004 | EP0831752B1 A device for delivering a preselected molecule into the systemic circulation |
| 09/01/2004 | CN1526018A Recombinant poxvirus for chimeric proteins of the human immunodeficiency virus |
| 09/01/2004 | CN1526011A Inhibition of apoptosis process and improvement of cell performance |
| 09/01/2004 | CN1525977A Purification of human serum albumin |
| 09/01/2004 | CN1525863A Lipoteichoic acid from lactic acid bacteria and its use to modulate immune responses mediated by gram-negative, potential pathogenic gram-positive bacteria |
| 09/01/2004 | CN1524952A False virosome vaccine with recombinant replicon of dengue fever virus as carrier |
| 09/01/2004 | CN1524951A Vaccine for human papiloma virus |
| 09/01/2004 | CN1524581A Polymer micelle medicine-carrying system |
| 09/01/2004 | CN1524575A Virulence genes and proteins, and their use |
| 09/01/2004 | CN1524565A Medicine for treatment of ischemic necrosis of fermoral head |
| 09/01/2004 | CN1524545A Health care diet therapy preparation of ultrafine broad spectrum immune olyrhachis ants and the preparation method thereof |
| 09/01/2004 | CN1524538A Chinese traditional medicine composition for treating epilepsy |
| 09/01/2004 | CN1524537A Pharmaceutical composition for treaitng coronary heart disease |
| 09/01/2004 | CN1524536A Technology for producing sheep placenta biolobical preparations using low-temperature ultrasonic high-pressure egg albumen cracking method |
| 09/01/2004 | CN1164944C Biological assay method of royal jelly and freeze-dried powder activity |
| 09/01/2004 | CN1164761C Process for producing product contg. antihypertensive tripeptides |
| 09/01/2004 | CN1164756C Nucleic acid transporter containing polypeptide and recombinant virus vector |
| 09/01/2004 | CN1164730C Black ant liquor |
| 09/01/2004 | CN1164325C Antiphlogistic capsule capable of keeping the adverse energy downwards |
| 09/01/2004 | CN1164319C Medicament for treating epistaxis |
| 09/01/2004 | CN1164316C Capsule for treating leucopenia disease and its preparation method |
| 09/01/2004 | CN1164312C Solid antitussive ointment and preparation method thereof |
| 09/01/2004 | CN1164309C Medicament for treating cancer |
| 09/01/2004 | CN1164308C Osteological Chinese medicine preparation |
| 09/01/2004 | CN1164306C Chinese medicine for curing hyperosteogeny, cervical spondylopathy and prolapse of lumbar intervertebral disk and its preparation method |
| 09/01/2004 | CN1164305C Medicinal powder for curing laryngopharyngitis and ulcerations of the oral cavity |
| 09/01/2004 | CN1164303C Chinese medicine for treating bradyrhythmia caused by hypotension |
| 09/01/2004 | CN1164300C Pure traditional Chinese medicine for relaxing muscles and tendons and promoting blood circulation |
| 09/01/2004 | CN1164299C Keyan Oral liquid as Chinese medicine preparation for treating acute or chronic inflammation and its preparing process |
| 09/01/2004 | CN1164298C Chinese medicine for treating cold and cough and its preparation method |
| 09/01/2004 | CN1164296C Powder for treating bone fracture |
| 09/01/2004 | CN1164294C Liver cancer resisting medicine |
| 09/01/2004 | CN1164293C Chinese-medicinal capsule for treating cardiovascular and cerebrovascular diseases |
| 09/01/2004 | CN1164291C Chinese proprietary for treating protrusion of lumber interverterbral disc and its prepn. |
| 09/01/2004 | CN1164287C Composite Chinese medicine for treating burns and scalds |
| 09/01/2004 | CN1164283C Pneumonia treating Chinese medicine powder |
| 09/01/2004 | CN1164281C Qibeifeian particles for treating cancer of lung and its preparing process |
| 09/01/2004 | CN1164280C Tibet medicine for treating angiocardiopathy and cerebrovascular disease |
| 09/01/2004 | CN1164279C Mixed live bacillus drops of bifidobacterium and lactobacillaceau and its prepn |
| 09/01/2004 | CN1164278C Biological preparation for curing burn and its preparation method |
| 09/01/2004 | CN1164277C Coma treating medicine composition |
| 09/01/2004 | CN1164276C Method of in vitro culturing medicine ox gallstone with natural ox gall |
| 08/31/2004 | US6783987 Recovering leucocyte components from human blood; obtain cells, break cells, separate leukocyte components, recover components |
| 08/31/2004 | US6783981 Capable of delivering anti-viral inhibitory rna molecules to target cells; gene therapy |
| 08/31/2004 | US6783977 Internal ribosome entry site and vector containing same |
| 08/31/2004 | US6783964 Microencapsulated pancreatic islet cells |
| 08/31/2004 | US6783935 Genetic polymorphism of MxA protein and use thereof |
| 08/31/2004 | US6783780 Nutritional supplement for the prevention and/or treatment of disorders of the digestive tract, which comprises probiotics comprising a lactic acid bacterial strain and a yeast strain of a saccharomyces species and non-digestable oligosaccharides |
| 08/31/2004 | US6783775 Comprising ceruloplasmin and a serum-derived composition (sdf) having a low molecular weight, electrically charged at acidic ph and having absorption at 280 mn, capable of inducing terminal cell differentiation of leukemic cells |
| 08/27/2004 | CA2458001A1 Regulation of immune responses by manipulation of intermediary metabolite levels |
| 08/26/2004 | WO2004072272A1 Bacterial compositions |
| 08/26/2004 | WO2004072100A2 Nell peptide expression systems and bone formation activity of nell peptide |
| 08/26/2004 | WO2004071520A1 Bifidobacterium preparation for improving immune functions |
| 08/26/2004 | WO2004071519A1 Photosynthetic micro-organisms enriched with biologically-active molecules, preparation method thereof and uses of same |
| 08/26/2004 | WO2004071416A2 Novel inhibitors of formation of advanced glycation endproducts (ages) |
| 08/26/2004 | WO2004071414A2 Therapeutic anti-hcv (al9) compounds |
| 08/26/2004 | WO2004071283A2 Use of umbilical cord blood to treat individuals having a disease, disorder or condition |
| 08/26/2004 | WO2004044163A9 Methods for identifying risk of melanoma and treatments thereof |
| 08/26/2004 | WO2004035787A3 Transplantable cell with immune modulator |
| 08/26/2004 | WO2004022724A3 Adoptive transfer and uses thereof |
| 08/26/2004 | WO2004013310A3 Methods of down regulating target gene expression in vivo by introduction of interfering rna |